Market Cap

Kindred Biosciences, Inc. Market Capitalization:

$414.6 Million

USD as of July 1, 2021

business Kindred Biosciences, Inc. Company Profile

Kindred Biosciences, Inc. Main Stock Listing

NASDAQ: KIN

Market Capitalization History of Kindred Biosciences, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $89.09 B
MERCK Kommanditgesellschaft auf Aktien $67.64 B
Takeda Pharmaceutical Company Limited $47.71 B
Haleon plc $38.90 B
PPD, Inc. $16.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Kindred Biosciences, Inc. market cap

Date Market Cap YoY Change

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Kindred Biosciences, Inc. Categories

United States languages Healthcare languages Drug Manufacturers—Specialty & Generic
United States Healthcare United States Drug Manufacturers—Specialty & Generic

Stocks & Indices

Kindred Biosciences, Inc. has the following listings and related stock indices.


Stock: NASDAQ: KIN

Stock: FSX: 17K

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.